secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lucid Diagnostics Inc. (LUCD)
CIK:        0001799011
Form:       8-K
Filed at:   2023-06-21T23:59:59+00:00
Accession:  0001493152-23-022033
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lucid Diagnostics stockholders approve doubling authorized shares to 200M and re-elect directors
--------------------------------------------------------------------------------

- Re-elected Class B directors Ronald M. Sparks and James L. Cox with over 94% of votes cast.
- Approved amendment increasing authorized common stock from 100M to 200M shares (37.1M for, 1.1M against).
- Approved officer exculpation amendment to certificate of incorporation (33.3M for).
- Approved issuance of shares under March 2023 convertible note and Series A preferred stock (both >99% votes cast).
- Ratified Marcum LLP as independent auditor for FY2023 (38.3M for, 18K against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799011/000149315223022033/0001493152-23-022033-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799011/000149315223022033/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-022033

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer